DrugCite
Search

TRUSOPT

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Trusopt Adverse Events Reported to the FDA Over Time

How are Trusopt adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Trusopt, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Trusopt is flagged as the suspect drug causing the adverse event.

Most Common Trusopt Adverse Events Reported to the FDA

What are the most common Trusopt adverse events reported to the FDA?

Eye Irritation
58 (3.17%)
Intraocular Pressure Increased
56 (3.06%)
Eye Pain
52 (2.84%)
Visual Acuity Reduced
38 (2.07%)
Dyspnoea
37 (2.02%)
Product Substitution Issue
31 (1.69%)
Ocular Hyperaemia
30 (1.64%)
Blindness
22 (1.2%)
Drug Ineffective
22 (1.2%)
Vision Blurred
22 (1.2%)
Eye Disorder
19 (1.04%)
Show More Show More
Headache
19 (1.04%)
Nausea
19 (1.04%)
Vitreous Opacities
19 (1.04%)
Ectropion
18 (.98%)
Laceration
18 (.98%)
Pruritus
18 (.98%)
Scotoma
18 (.98%)
Dizziness
17 (.93%)
Erythema
17 (.93%)
Tinnitus
17 (.93%)
Vitreous Detachment
17 (.93%)
Cough
15 (.82%)
Choroidal Detachment
14 (.76%)
Conjunctival Oedema
14 (.76%)
Drug Hypersensitivity
14 (.76%)
Eyelid Oedema
14 (.76%)
Hypersensitivity
14 (.76%)
Pain
14 (.76%)
Palpitations
14 (.76%)
Skin Exfoliation
14 (.76%)
Eye Pruritus
13 (.71%)
Chest Discomfort
12 (.66%)
Eye Swelling
12 (.66%)
Growth Of Eyelashes
12 (.66%)
Periorbital Oedema
12 (.66%)
Toxic Epidermal Necrolysis
12 (.66%)
Corneal Oedema
11 (.6%)
Dermatitis
11 (.6%)
Fatigue
11 (.6%)
Hypertension
11 (.6%)
Abnormal Dreams
10 (.55%)
Blood Pressure Decreased
10 (.55%)
Conjunctivitis
10 (.55%)
Corneal Disorder
10 (.55%)
Maculopathy
10 (.55%)
Nasal Congestion
10 (.55%)
Nephropathy Toxic
10 (.55%)
Anosmia
9 (.49%)
Blepharoplasty
9 (.49%)
Drug Rash With Eosinophilia And Sys...
9 (.49%)
Fall
9 (.49%)
Hyphaema
9 (.49%)
Cataract
8 (.44%)
Iridocyclitis
8 (.44%)
Photophobia
8 (.44%)
Rash
8 (.44%)
Somnolence
8 (.44%)
Blepharitis
7 (.38%)
Bradycardia
7 (.38%)
Condition Aggravated
7 (.38%)
Conjunctival Hyperaemia
7 (.38%)
Depression
7 (.38%)
Lacrimation Increased
7 (.38%)
Visual Field Defect
7 (.38%)
Visual Impairment
7 (.38%)
Acute Generalised Exanthematous Pus...
6 (.33%)
Blindness Unilateral
6 (.33%)
Corneal Erosion
6 (.33%)
Diplopia
6 (.33%)
Dry Mouth
6 (.33%)
Dysgeusia
6 (.33%)
Foreign Body Sensation In Eyes
6 (.33%)
Glaucoma
6 (.33%)
Intraocular Lens Implant
6 (.33%)
Ocular Hypertension
6 (.33%)
Overdose
6 (.33%)
Phacotrabeculectomy
6 (.33%)
Photocoagulation
6 (.33%)
Product Quality Issue
6 (.33%)
Renal Impairment
6 (.33%)
Throat Tightness
6 (.33%)
Adverse Event
5 (.27%)
Amblyopia
5 (.27%)
Asthenia
5 (.27%)
Epistaxis
5 (.27%)
Eyelid Irritation
5 (.27%)
Feeling Cold
5 (.27%)
Hair Disorder
5 (.27%)
Heart Rate Decreased
5 (.27%)
Heart Rate Irregular
5 (.27%)
Hypoaesthesia
5 (.27%)
Intraocular Pressure Fluctuation
5 (.27%)
Iritis
5 (.27%)
Macular Oedema
5 (.27%)
Metabolic Acidosis
5 (.27%)
Oesophageal Carcinoma
5 (.27%)
Paralysis
5 (.27%)
Poor Quality Drug Administered
5 (.27%)
Reading Disorder
5 (.27%)
Spinal Column Stenosis
5 (.27%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Trusopt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Trusopt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Trusopt

What are the most common Trusopt adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Trusopt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Trusopt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Trusopt According to Those Reporting Adverse Events

Why are people taking Trusopt, according to those reporting adverse events to the FDA?

Glaucoma
478
Intraocular Pressure Increased
79
Open Angle Glaucoma
51
Product Used For Unknown Indication
45
Drug Use For Unknown Indication
42
Ocular Hypertension
20
Show More Show More
Normal Tension Glaucoma
13
Venous Occlusion
9
Eye Disorder
9
Intraocular Pressure Test
8
Prophylaxis
7
Ill-defined Disorder
6
Developmental Glaucoma
4
Dry Eye
4
Intraocular Pressure Test Abnormal
3
Cataract
3
Prophylaxis Against Transplant Reje...
3
Postoperative Care
3
Intraocular Pressure Decreased
3
Macular Degeneration
2
Eye Oedema
2
Hypertonia
2
Behcets Syndrome
2
Abnormal Sensation In Eye
2
Keratoconus
1
Angle Closure Glaucoma
1
Optic Ischaemic Neuropathy
1
Retinal Scar
1
Corneal Disorder
1
Scleritis
1
Iritis
1
Off Label Use
1
Endophthalmitis
1
Unevaluable Event
1
Pyrexia
1
Glaucomatocyclitic Crises
1
Papilloedema
1
Bradycardia
1
Eye Pain
1
Retinal Haemorrhage
1

Drug Labels

LabelLabelerEffective
TrusoptMerck Sharp & Dohme Corp.31-AUG-11

Trusopt Case Reports

What Trusopt safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Trusopt. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Trusopt.